Mechanisms and functions of serotonin neuronal systems: opportunities for neuropeptide interactions.
Fuller
R W
RW
Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
D000818:Animals; D002490:Central Nervous System / Q000502:physiology* / Q000503:physiopathology; D003346:Corticotropin-Releasing Hormone / Q000502:physiology; D005260:Female; D001523:Mental Disorders / Q000503:physiopathology; D008881:Migraine Disorders / Q000188:drug therapy; D009422:Nervous System Diseases / Q000503:physiopathology; D009474:Neurons / Q000502:physiology*; D009479:Neuropeptides / Q000502:physiology*; D011985:Receptors, Serotonin / Q000145:classification / Q000502:physiology*; D012701:Serotonin / Q000502:physiology*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D018170:Sumatriptan / Q000627:therapeutic use
D009479:Neuropeptides; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D012701:Serotonin; D018170:Sumatriptan; D003346:Corticotropin-Releasing Hormone